Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

MIRA Pharmaceuticals, Inc. Common Stock

MIRA
Current price
1.17 USD -0.13 USD (-10.00%)
Last closed 1.31 USD
Company
ISIN unknown
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 19 954 216 USD
Yield for 12 month -72.27 %
1Y
3Y
5Y
10Y
15Y
MIRA
21.11.2021 - 28.11.2021

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida. Address: 1200 Brickell Avenue, Miami, FL, United States, 32183

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-8 526 049 USD

Last Year

Current Quarter

-1 730 722 USD

Last Quarter

-1 768 187 USD

Key Figures MIRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -177.53 %
PEG Ratio
Return On Equity TTM -748.59 %
Wall Street Target Price 11.67 USD
Revenue TTM
Book Value 0.15 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.86 USD
Diluted Eps TTM -0.86 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MIRA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MIRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MIRA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.4534
Price Book MRQ 8.9926

Financials MIRA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MIRA

For 52 weeks

0.51 USD 6.4 USD
50 Day MA 1.75 USD
Shares Short Prior Month 372 410
200 Day MA 1.25 USD
Short Ratio 0.21
Shares Short 593 888
Short Percent 5.52 %